Bioverativ
Why Robinhood?
You can watch Bioverativ and buy or sell other stocks, ETFs, and their options commission-free!About BIVV
Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA.
BIVV Key Statistics
Stock Snapshot
The current Bioverativ(BIVV) stock price is $104.65, with a market capitalization of 11.36B. The stock trades at a price-to-earnings (P/E) ratio of 32.01.
Bioverativ(BIVV) stock opened on 2026-04-05 at —. The price climbed to — and dipped to —.
The Bioverativ(BIVV)'s current trading volume is 0, compared to an average daily volume of 3.24M.
In the last year, Bioverativ(BIVV) shares hit a 52-week high of $105.01 and a 52-week low of $48.14.
In the last year, Bioverativ(BIVV) shares hit a 52-week high of $105.01 and a 52-week low of $48.14.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.